COMMUNIQUÉ DE PRESSE publié le 22/10/2025 à 12:05, il y a 1 année Cambrex Unveils $120 Million Investment to Expand API Manufacturing and Strengthen U.S. Drug Supply Resilience Cambrex announces $120 million investment to expand API manufacturing in the U.S., strengthening drug supply resilience and supporting reshoring initiatives. The investment will increase manufacturing capacity by 40% Pharmaceutical Industry Investment API Manufacturing Cambrex Drug Supply Resilience
Publié le 30/10/2026 à 23:00, il y a 17 heures 37 minutes BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Publié le 30/10/2026 à 23:00, il y a 17 heures 37 minutes Biophytis publie les résultats du premier semestre 2026 et fait le point sur sa stratégie
Publié le 30/10/2026 à 23:35, il y a 17 heures 2 minutes Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Publié le 30/10/2026 à 23:30, il y a 17 heures 7 minutes Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Publié le 30/10/2026 à 20:47, il y a 19 heures 50 minutes CoTec Holdings Corp. Comments on Share Trading
Publié le 30/10/2026 à 19:00, il y a 21 heures 37 minutes Electric Royalties Ltd. Announces Application for Warrant Extension
Publié le 30/10/2026 à 15:30, il y a 1 jour 1 heure Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Publié le 30/10/2026 à 22:49, il y a 17 heures 48 minutes EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Publié le 30/10/2026 à 18:38, il y a 21 heures 59 minutes EQS-Adhoc: Starcom Holding AD publishes Interim Q3 2026 Financial Report
